March 31, 2026
-April 02, 2026
Apollo Therapeutics is pleased to share that CEO Richard Mason, CFO Jamie Heath, and Director, Corporate Finance Kalon Hewage will be participating in the Wells Fargo Virtual Private Biopharma Symposium on April 8. The Apollo team will be taking part in one‑on‑one and group meetings throughout the day.